Fractional factorial experiments often produce ambiguous results due to confounding among the factors; as a consequence more than one model is consistent with the data. Thus, the practical problem is how to choose additional runs in order to discriminate among the rival models and to identify the active factors. The R package OBsMD solves this problem by implementing the objective Bayesian methodology proposed by Consonni and Deldossi (2016). The main feature of this approach is that the follow-up designs are obtained through the use of just two functions, OBsProb() and OMD() without requiring any prior specifications, being fully automatic. Thus OBsMD provides a simple tool for conducting a design of experiments to solve real world problems.

R Package OBsMD for Follow-Up Designs in an Objective Bayesian Framework

Marta Nai Ruscone
2020-01-01

Abstract

Fractional factorial experiments often produce ambiguous results due to confounding among the factors; as a consequence more than one model is consistent with the data. Thus, the practical problem is how to choose additional runs in order to discriminate among the rival models and to identify the active factors. The R package OBsMD solves this problem by implementing the objective Bayesian methodology proposed by Consonni and Deldossi (2016). The main feature of this approach is that the follow-up designs are obtained through the use of just two functions, OBsProb() and OMD() without requiring any prior specifications, being fully automatic. Thus OBsMD provides a simple tool for conducting a design of experiments to solve real world problems.
File in questo prodotto:
File Dimensione Formato  
v94i02.pdf

accesso aperto

Tipologia: Documento in versione editoriale
Dimensione 670.51 kB
Formato Adobe PDF
670.51 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11567/1017075
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact